POMx
This article was originally published in The Tan Sheet
Executive Summary
POM Wonderful has developed and patented a form of polyphenol antioxidants from pomegranate that is "so concentrated that only a small amount is needed to obtain an optimal level of daily antioxidants," according to the Los Angeles, Calif.-based firm. "For consumers who are not seeking additional calories and sugars, this is an important product benefit." POMx currently is available to consumers as the active ingredient in POM Tea, which launched in May. At this time, POM Wonderful has no plans to offer the compound in non-beverage products, according to a spokesperson. The announcement of the ingredient's availability follows the publication of several recent studies on the health benefits of pomegranates, including a July 1 Clinical Cancer Research study finding that a daily regime of POM Wonderful juice prolonged prostate-specific antigen (PSA) doubling time from 15 to 54 months. The study was supported by a grant from the firm...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.